ID
32192
Description
Study ID: 109563 Clinical Study ID: 109563 Study Title: COMPAS:A phase III study to demonstrate efficacy of GSK Biologicals' 10-valent pneumococcal vaccine (GSK1024850A) against Community Acquired Pneumonia and Acute Otitis Media Patient Level Data: Study Listed on https://clinicaltrials.gov/ct2/show/NCT00466947 Clinicaltrials.gov Identifier: NCT00466947 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: Pneumococcal Polysaccharide Conjugate Vaccine (Adsorbed) Trade Name: BIO 10PN-PD-DIT; Synflorix Study Indication: Infections, Streptococcal The Study consists of three workbooks. Workbook 1: Argentina, all subjects + immuno & reacto subset Workbook 2: Panama, all subjects + immuno & reacto subset + carriage subset + additional immuno subset Workbook 3: Colombia, all subjects The protocol number for all workbooks: 109563 (10Pn-PD-DiT-028) There are ten visits in workbook 1 and 2, eight for workbook 3 (there are no visits 4 and 7): Visit 1: month 0, dose 1, 6-16 weeks of age Visit 2: month 2, dose 2, +/- 4 months of age, 49-83 days after visit 1 Visit 3: month 4, dose 3, +/- 6 months of age, 49-83 days after visit 2 Visit 4: month 5, +/- 7 months of age, 28-42 days after visit 3. Only for immuno & reacto subset + carriage subset. Visit 5: month 10-13, 12-15 months of age Visit 6: month 13-16, booster dose, 15-18 months of age, ≥ 28 days after visit 5 Visit 7: month 14-17, 16-19 months of age, 28-42 days after visit 6. Only for immuno & reacto subset, additional immuno subset + carriage subset. Visit 8: month 16-19, 18-21 months of age, ≥ 28 days after visit 6 Visit 9: month 22-25, 24-27 months of age Visit 10: Contact This document contains the check for study continuation and elimination criteria which has to be filled in for Visit 2-9. It also contains physical examination which has to be filled in for Visit 2-4, 6, 9. It's for all workbooks. The document also contains the informed consent form for "all subjects and carriage subset". This item is only for workbook 2 and has to be filled in only for visit 6.
Link
https://clinicaltrials.gov/ct2/show/NCT00466947
Keywords
Versions (3)
- 22/10/18 22/10/18 -
- 23/10/18 23/10/18 -
- 26/10/18 26/10/18 -
Copyright Holder
GlaxoSmithKline
Uploaded on
23 de octubre de 2018
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Vaccination against pneumonia and otitis media 109563, NCT00466947
Check for continuation, elimination criteria, physical examination
Description
CHECK FOR STUDY CONTINUATION
Alias
- UMLS CUI-1
- C0805733
- UMLS CUI-2
- C0008976
Description
If subject return to visit please complete the next pages
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0545082
- UMLS CUI [1,2]
- C0805733
Description
Please tick the ONE most appropriate reason and skip the following pages of this visit. If there is a SAE please complete and submit SAE report. If there is a AEX please complete Non-serious Adverse Event section. If there is an other reason for no return please specify in following item.
Data type
text
Alias
- UMLS CUI [1,1]
- C1298908
- UMLS CUI [1,2]
- C0545082
- UMLS CUI [1,3]
- C0805733
- UMLS CUI [1,4]
- C0566251
Description
Please complete and submit SAE report
Data type
integer
Alias
- UMLS CUI [1,1]
- C1519255
- UMLS CUI [1,2]
- C0237753
Description
Please complete Non-serious Adverse Event section
Data type
integer
Alias
- UMLS CUI [1,1]
- C1518404
- UMLS CUI [1,2]
- C0237753
Description
In workbook 1 and 2 only for immuno and reato subset.
Data type
text
Alias
- UMLS CUI [1,1]
- C0683368
- UMLS CUI [1,2]
- C1517001
- UMLS CUI [1,3]
- C1518404
- UMLS CUI [1,4]
- C0805701
Description
(e.g.: consent withdrawal, Protocol violation, …)
Data type
text
Alias
- UMLS CUI [1,1]
- C3840932
- UMLS CUI [1,2]
- C1298908
- UMLS CUI [1,3]
- C0805733
Description
Decision made by Investigator, Parents/Guardians
Data type
text
Alias
- UMLS CUI [1,1]
- C0679006
- UMLS CUI [1,2]
- C0008961
- UMLS CUI [2,1]
- C0679006
- UMLS CUI [2,2]
- C0030551
- UMLS CUI [2,3]
- C0023226
Description
ELIMINATION CRITERIA
Alias
- UMLS CUI-1
- C0680251
Description
Please tick all that applies in following items. Note: Please check exclusion criteria for further participation (only if subject returns at the visit)
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0680251
- UMLS CUI [1,2]
- C1706839
Description
For Visit 3-9
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0566251
- UMLS CUI [1,2]
- C0445247
- UMLS CUI [1,3]
- C0205156
- UMLS CUI [1,4]
- C0545082
Description
Chronic administration is defined as more than 14 days
Data type
boolean
Alias
- UMLS CUI [1]
- C0680251
- UMLS CUI [2,1]
- C0021081
- UMLS CUI [2,2]
- C0205191
- UMLS CUI [3]
- C0005525
Description
Elimination criteria: Major congenital defects/serious chronic illness.
Data type
boolean
Alias
- UMLS CUI [1]
- C0680251
- UMLS CUI [2,1]
- C0220810
- UMLS CUI [2,2]
- C0205164
- UMLS CUI [3,1]
- C0008679
- UMLS CUI [3,2]
- C0205404
Description
Elimination criteria: confirmed/suspected immunosuppressive/immunodeficient condition.
Data type
boolean
Alias
- UMLS CUI [1]
- C0680251
- UMLS CUI [2,1]
- C0750484
- UMLS CUI [2,2]
- C3829792
- UMLS CUI [3,1]
- C0750484
- UMLS CUI [3,2]
- C4048329
- UMLS CUI [4,1]
- C0242114
- UMLS CUI [4,2]
- C3829792
- UMLS CUI [5,1]
- C0242114
- UMLS CUI [5,2]
- C4048329
Description
Elimination criteria: immunoglobulins/any blood derived products
Data type
boolean
Alias
- UMLS CUI [1]
- C0680251
- UMLS CUI [2]
- C0021027
- UMLS CUI [3]
- C0456388
Description
Elimination criteria: use of investigational or non-registered product
Data type
boolean
Alias
- UMLS CUI [1]
- C0680251
- UMLS CUI [2,1]
- C0304229
- UMLS CUI [2,2]
- C0332300
- UMLS CUI [2,3]
- C0042210
- UMLS CUI [2,4]
- C2348563
Description
Physical examination
Alias
- UMLS CUI-1
- C0031809
Description
ADDITIONAL IMMUNO ICF
Alias
- UMLS CUI-1
- C0021430
Description
If yes please complete blood sample question at this visit (if visit is performed) and perform Visit 7. Note: → All parents/guardians who signed their initial ICF of the group “All subjects” or “Carriage” and decided to be part of the Additional IR subgroup must answer “Yes” to this question. → All parents/guardians who did not perform Visit 6 must answer “NA” to this question.
Data type
integer
Alias
- UMLS CUI [1,1]
- C0021430
- UMLS CUI [1,2]
- C0030551
- UMLS CUI [2,1]
- C0021430
- UMLS CUI [2,2]
- C0023226
Similar models
Check for continuation, elimination criteria, physical examination
C0008976 (UMLS CUI-2)
C0805733 (UMLS CUI [1,2])
C0545082 (UMLS CUI [1,2])
C0805733 (UMLS CUI [1,3])
C0566251 (UMLS CUI [1,4])
C0237753 (UMLS CUI [1,2])
C0237753 (UMLS CUI [1,2])
C1517001 (UMLS CUI [1,2])
C1518404 (UMLS CUI [1,3])
C0805701 (UMLS CUI [1,4])
C1298908 (UMLS CUI [1,2])
C0805733 (UMLS CUI [1,3])
C0008961 (UMLS CUI [1,2])
C0679006 (UMLS CUI [2,1])
C0030551 (UMLS CUI [2,2])
C0023226 (UMLS CUI [2,3])
C1706839 (UMLS CUI [1,2])
C0445247 (UMLS CUI [1,2])
C0205156 (UMLS CUI [1,3])
C0545082 (UMLS CUI [1,4])
C0021081 (UMLS CUI [2,1])
C0205191 (UMLS CUI [2,2])
C0005525 (UMLS CUI [3])
C0220810 (UMLS CUI [2,1])
C0205164 (UMLS CUI [2,2])
C0008679 (UMLS CUI [3,1])
C0205404 (UMLS CUI [3,2])
C0750484 (UMLS CUI [2,1])
C3829792 (UMLS CUI [2,2])
C0750484 (UMLS CUI [3,1])
C4048329 (UMLS CUI [3,2])
C0242114 (UMLS CUI [4,1])
C3829792 (UMLS CUI [4,2])
C0242114 (UMLS CUI [5,1])
C4048329 (UMLS CUI [5,2])
C0021027 (UMLS CUI [2])
C0456388 (UMLS CUI [3])
C0304229 (UMLS CUI [2,1])
C0332300 (UMLS CUI [2,2])
C0042210 (UMLS CUI [2,3])
C2348563 (UMLS CUI [2,4])
C0030551 (UMLS CUI [1,2])
C0021430 (UMLS CUI [2,1])
C0023226 (UMLS CUI [2,2])